Position in BIOA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,320,026
+$5,244,252 QoQ
Shares Held
257,855
+319.2% QoQ
Ownership
0.562%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 151 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $1,596,028,663 across 49 Drug Manufacturers - Specialty & Generic names. BIOA ranks #25 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,924,926 | $282,045,178 | |
| 2 | LQDA |
Liquidia Corp
|
1,991,566 | $158,787,554 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,227,607 | $143,231,322 | |
| 4 | VTRS |
Viatris Inc
|
7,356,708 | $116,824,520 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
619,352 | $104,385,582 | |
| 6 | HLN |
Haleon plc
|
10,850,097 | $101,231,403 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
179,235 | $97,114,896 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
3,909,871 | $96,221,922 |
All Filings in BIOA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,320,026 | 257,855 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,075,774 | 61,508 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $2,496,275 | 188,683 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $65,378 | 11,119 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $31,395 | 7,602 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $23,033 | 6,126 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $114,751 | 19,819 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $10,919 | 525 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||